Published in Stem Cells on January 01, 2004
Evasion of myofibroblasts from immune surveillance: a mechanism for tissue fibrosis. Proc Natl Acad Sci U S A (2007) 1.01
Tolerogenic dendritic cells and their potential applications. Immunology (2011) 0.88
Alloantigen specific deletion of primary human T cells by Fas ligand (CD95L)-transduced monocyte-derived killer-dendritic cells. Immunology (2011) 0.82
Treatment of surgical brain injury by immune tolerance induced by intrathymic and hepatic portal vein injection of brain antigens. Sci Rep (2016) 0.75
Characterization of clonogenic multiple myeloma cells. Blood (2003) 5.35
CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc Natl Acad Sci U S A (2007) 4.06
Mobile interspersed repeats are major structural variants in the human genome. Cell (2010) 3.60
Notch inhibits Ptf1 function and acinar cell differentiation in developing mouse and zebrafish pancreas. Development (2004) 2.21
Lentiviral vectors with two independent internal promoters transfer high-level expression of multiple transgenes to human hematopoietic stem-progenitor cells. Mol Ther (2003) 1.87
Kruppel-like factor 4 is essential for inflammatory monocyte differentiation in vivo. J Immunol (2008) 1.83
Improved methods for the generation of human gene knockout and knockin cell lines. Nucleic Acids Res (2005) 1.75
Microarray and serial analysis of gene expression analyses identify known and novel transcripts overexpressed in hematopoietic stem cells. Cancer Res (2004) 1.68
HES1 inhibits cycling of hematopoietic progenitor cells via DNA binding. Stem Cells (2006) 1.66
C/EBPalpha directs monocytic commitment of primary myeloid progenitors. Blood (2006) 1.31
Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile. Blood (2013) 1.16
Targeted manipulation of mammalian genomes using designed zinc finger nucleases. Biochem Biophys Res Commun (2009) 1.15
TEL-AML1, expressed from t(12;21) in human acute lymphocytic leukemia, induces acute leukemia in mice. Cancer Res (2002) 1.06
MiR-27a functions as a tumor suppressor in acute leukemia by regulating 14-3-3θ. PLoS One (2012) 1.04
Late stage erythroid precursor production is impaired in mice with chronic inflammation. Haematologica (2012) 1.02
Immunotherapy of established tumors using bone marrow transplantation with antigen gene--modified hematopoietic stem cells. Nat Med (2003) 1.00
Activating signals dominate inhibitory signals in CD137L/IL-15 activated natural killer cells. J Immunother (2011) 0.98
Human stem-progenitor cells from neonatal cord blood have greater hematopoietic expansion capacity than those from mobilized adult blood. Exp Hematol (2002) 0.95
TAGmapper: a web-based tool for mapping SAGE tags. Gene (2005) 0.95
Acceleration of G(1) cooperates with core binding factor beta-smooth muscle myosin heavy chain to induce acute leukemia in mice. Cancer Res (2002) 0.88
Deletion of tristetraprolin caused spontaneous reactive granulopoiesis by a non-cell-autonomous mechanism without disturbing long-term hematopoietic stem cell quiescence. J Immunol (2011) 0.88
Translational research: toward better characterization of human embryonic stem cell lines. Stem Cells (2005) 0.88
Selective reduction of graft-versus-host disease-mediating human T cells by ex vivo treatment with soluble Fas ligand. J Immunol (2009) 0.87
Human CD34+ hematopoietic stem/progenitor cells express high levels of FLIP and are resistant to Fas-mediated apoptosis. Stem Cells (2002) 0.86
Investigation of the role of interleukin-6 and hepcidin antimicrobial peptide in the development of anemia with age. Haematologica (2013) 0.85
Hepcidin-dependent and hepcidin-independent regulation of erythropoiesis in a mouse model of anemia of chronic inflammation. Am J Hematol (2014) 0.85
High-efficiency stable gene transduction in primary human melanocytes using a lentiviral expression system. J Invest Dermatol (2004) 0.84
c-Myc overcomes cell cycle inhibition by CBFbeta-SMMHC, a myeloid leukemia oncoprotein. Cancer Biol Ther (2002) 0.83
How many human embryonic stem cell lines are sufficient? A U.S. perspective. Stem Cells (2006) 0.82
MIR144 and MIR451 regulate human erythropoiesis via RAB14. Br J Haematol (2014) 0.80
A simple high-throughput technology enables gain-of-function screening of human microRNAs. Biotechniques (2013) 0.80
Artemisinin-derived dimer phosphate esters as potent anti-cytomegalovirus (anti-CMV) and anti-cancer agents: a structure-activity study. Bioorg Med Chem (2013) 0.78
Ex vivo soluble fas ligand treatment of donor cells to selectively reduce murine acute graft versus host disease. Transplantation (2006) 0.78
Identification of miR-145 targets through an integrated omics analysis. Mol Biosyst (2014) 0.77
Profiling tumor counterattack: do Fas ligand-containing microvesicles reduce anticancer immunity? Clin Cancer Res (2005) 0.75
Digital HLA allelotyping. Cancer Biol Ther (2004) 0.75
Editorial retraction. Stem Cells (2006) 0.75
Commitment to biomedical research: clearing unnecessary impediments to progress. Stem Cells (2002) 0.75
Advancing the fast-paced field of stem cell research: stem cells increases from 6 to 10 issues in its 23rd year of publication. Stem Cells (2005) 0.75
Troublesome questions. Stem Cells (2006) 0.75
Two steps forward: keeping the momentum in stem cell research. Stem Cells (2004) 0.75